ResearcherGabrail Cancer CenterActive in the last 2 years
Nashat Y. Gabrail
Matched on ORCID iD 0009-0007-3885-3622; OpenAlex author ID A5111512954. Sources: ClinicalTrials.gov.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 1 (principal investigator on 1)
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2014: 1 trial · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 3
- Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 St… Co-author DOI 10.1200/jco-25-00746↗
- A Phase 2 Study of PCI-27483, a Factor VIIa Inhibitor in Combination with Gemcitabine for Advanced Pancreatic Cancer. Last author DOI 10.1159/000495988↗
- Phase I/II study of mocetinostat in combination with gemcitabine for patients with advanced pancreatic cancer and other advanced solid tumors. Co-author DOI 10.1007/s00280-017-3494-3↗
Trials 1
- KPT-330 to Treat Poorly Differentiated Lung and Gastroenteropancreatic Tumors Principal investigator NCT02250885↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Alok A. Khorana · 1 shared paper, 2019 · strength 0.10
- Ramesh K. Ramanathan · 1 shared paper, 2019 · strength 0.10
- Peter James O'Dwyer · 1 shared paper, 2018 · strength 0.09
- Emily W. Chan · 1 shared paper, 2018 · strength 0.09
- Herbert I. Hurwitz · 1 shared paper, 2018 · strength 0.09
- Elena Gabriela Chiorean · 1 shared paper, 2018 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.